1.

The Drug Controller General of India (DCGI) approved a trial of a drug, Sepsivac for reducing mortality rate in critically ill COVID-19 patients. The Drug is developed by ______________ .

A. Shree Kalyan Ayurvedic Pharmacy
B. Cadila Pharmaceuticals Ltd.
C. Astemax Biotech Private Limited
D. Delphis Pharmaceutical India
E. None of these
Answer» C. Astemax Biotech Private Limited


Discussion

No Comment Found

Related MCQs